Jury rules Qiagen infringed two gene patents
31-08-2021
PTAB rejects IPR challenges to Gilead patents
14-06-2018
PTAB invalidates Johnson & Johnson cancer drug patent
18-01-2018
olm26250 / iStockphoto.com
Biotechnology company Qiagen has failed in its bid to stop diagnostics company HandyLab from retaining a patent for a diagnostic system, according to a decision issued by the US Patent Trial and Appeal Board on Tuesday, July 14.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
HandyLab, Qiagen, PTAB, Biotechnology, NeuMoDx, Becton, Dickinson & Co,, diagnostics, diagnostic system, patent, Delaware
